As fund managers reopen their offices, what can they ask employees about coronavirus vaccines and tests? What can managers require of employees? How should any information gathered be handled internally, and how can it be disclosed externally? This second article in our two-part series answers those questions and others to shed light on fund managers’ obligations and risks related to gathering, storing, providing access to and disclosing coronavirus-related employee data. The first article explored the applicable privacy and employment laws and provided steps managers can take to find the right balance when developing vaccine and testing policies. See “How Fund Managers Can Withstand the Coronavirus Pandemic: Marketing Disruptions, Key Person Clauses and Cybersecurity Concerns (Part Two of Three)” (Apr. 9, 2020).